Souhaitez-vous accéder aux communiqués récents ?

MicrobiotiX and WAFCIRC sign MoU and Research Collaboration Agreement in Ghana, launching clinical research to evaluate phage therapy for AMR infections.

GE Medical Holding AB exercises all its Warrants in EXACT Therapeutics resulting in gross proceeds of NOK 33 million. Reference is made to the stock exchange announcement published on 27 January 2026...

Beghou Names Meredith Ressi President and Chief Growth Officer to optimize for client experience and success.

“Pharmaceutical Filtration: Global Markets,” the market is expected to grow from $12 billion in 2025 and to reach $20.3 billion by the end of 2030.

Global GLP-1 Analogues Market report, the market was valued at $54.8 billion in 2024 and is projected to reach $268.4 billion by 2030.

mRNA-3927 si inserisce strategicamente nel portafoglio delle malattie rare metaboliche di Recordati La collaborazione unisce l’expertise di Moderna nella tecnologia mRNA per i disturbi metabolicirari...

RECORDATI ANNOUNCES STRATEGIC COLLABORATION WITH MODERNA TO DEVELOP AND COMMERCIALIZE WORLDWIDE mRNA 3927 FOR THE TREATMENT OF PROPIONIC ACIDEMIA

Beghou's 2026 Biopharma Commercialization Research Report distills key insights, challenges, and operational realities for 2026 and beyond.

Market growth is fueled by rising R&D investments, increasing trial complexity, and demand for faster, more cost-effective drug development.

Delray Beach, FL, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The Methyl Cellulose Market size is valued at USD 3.64 billion in 2025 and is expected to reach USD 5.88 billion by 2030, at a CAGR of 10.0%...